Growing incidence of cancer and cardiovascular disease driving nuclear medicine market

The global nuclear medicine market is expected to grow at a compound annual growth rate of over 8 percent from 2016 to 2020. What’s driving its growth? According to a new report, it’s the same conditions that are topping global mortality lists — cardiovascular disease and cancer.

Over 14 million new cases of cancer are reported globally every year, according to studies conducted by Cancer Research UK in 2012. The most common cancers are lung, breast, bowel and prostate cancer. Read more.